SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-23-000796
Filing Date
2023-08-10
Accepted
2023-08-10 16:10:51
Documents
79
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q igcpharma20230630_10q.htm   iXBRL 10-Q 852776
2 EXHIBIT 31.1 ex_556783.htm EX-31.1 14768
3 EXHIBIT 31.2 ex_556784.htm EX-31.2 14684
4 EXHIBIT 32.1 ex_556785.htm EX-32.1 7539
10 igcpharma_logo1.jpg GRAPHIC 8508
11 logo_2sm.jpg GRAPHIC 1941
  Complete submission text file 0001185185-23-000796.txt   5252432

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA igc-20230630.xsd EX-101.SCH 49044
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE igc-20230630_cal.xml EX-101.CAL 41760
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20230630_def.xml EX-101.DEF 211497
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20230630_lab.xml EX-101.LAB 403770
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20230630_pre.xml EX-101.PRE 225578
73 EXTRACTED XBRL INSTANCE DOCUMENT igcpharma20230630_10q_htm.xml XML 842787
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-32830 | Film No.: 231159450
SIC: 2834 Pharmaceutical Preparations